Karen Brown

28.3k total citations · 2 hit papers
184 papers, 8.8k citations indexed

About

Karen Brown is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Karen Brown has authored 184 papers receiving a total of 8.8k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Molecular Biology, 51 papers in Oncology and 47 papers in Genetics. Recurrent topics in Karen Brown's work include BRCA gene mutations in cancer (25 papers), Curcumin's Biomedical Applications (14 papers) and Carcinogens and Genotoxicity Assessment (14 papers). Karen Brown is often cited by papers focused on BRCA gene mutations in cancer (25 papers), Curcumin's Biomedical Applications (14 papers) and Carcinogens and Genotoxicity Assessment (14 papers). Karen Brown collaborates with scholars based in United Kingdom, United States and France. Karen Brown's co-authors include Andreas J. Gescher, William P. Steward, W P Steward, Ketan Patel, Victoria Brown, Lynne Howells, Robert G. Britton, Edwina N. Scott, Dean E. Brenner and Kenneth Offit and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Karen Brown

177 papers receiving 8.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Repeat Dose Study of the Cancer Chemopreventive Agent Resveratrol in Healthy Volunteers: Safety, Pharmacokinetics, and Effect on the Insulin-like Growth Factor Axis

2010 550 citations Karen Brown, William P. Steward et al. profile →
Resveratrol for the Management of Human Health: How Far Have We Come? A Systematic Review of Resveratrol Clinical Trials to Highlight Gaps and Opportunities

2024 75 citations Karen Brown, Robert G. Britton et al. International Journal of Molecular Sciences profile →

Peers

Countries citing papers authored by Karen Brown

Since Specialization

Citations

This map shows the geographic impact of Karen Brown's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen Brown with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen Brown more than expected).

Fields of papers citing papers by Karen Brown

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karen Brown. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen Brown. The network helps show where Karen Brown may publish in the future.

Co-authorship network of co-authors of Karen Brown

This figure shows the co-authorship network connecting the top 25 collaborators of Karen Brown. A scholar is included among the top collaborators of Karen Brown based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karen Brown. Karen Brown is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Relationship between household air pollution and lung cancer in never smokers in high-income countries: a systematic review 2025 ·BMJ Open ·(unknown), (unknown), Yutong Cai, Karen Brown, (unknown), Sam Khan	2
2	Age at type 2 diabetes diagnosis and risk of cancer: Cohort study in over 1 million individuals from the TriNetX US Collaborative Network 2025 ·Journal of Diabetes and its Complications ·(unknown), Gema Hernández, Zuzanna Drebert, Joseph Henson, (unknown), Francesco Zaccardi, Jack A. Sargeant, Karen Brown, David R. Webb, Dimitris Papamargaritis, Juliana C.N. Chan, Edward W. Gregg, (unknown), Melanie J. Davies, Thomas Yates	0
3	Redox modulation of oxidatively-induced DNA damage by ascorbate enhances both in vitro and ex-vivo DNA damage formation and cell death in melanoma cells 2024 ·Free Radical Biology and Medicine ·(unknown), (unknown), Gerald Saldanha, Karen Brown, Marcus S. Cooke, George D.D. Jones	3
4	Resveratrol for the Management of Human Health: How Far Have We Come? A Systematic Review of Resveratrol Clinical Trials to Highlight Gaps and Opportunities breakdown → 2024 ·International Journal of Molecular Sciences ·Karen Brown, (unknown), Robert G. Britton, (unknown), Coral Pepper, (unknown), Lynne Howells	75
5	Inequalities in cancer mortality trends in people with type 2 diabetes: 20 year population-based study in England 2023 ·Diabetologia ·Suping Ling, Francesco Zaccardi, Eyad Issa, Melanie J. Davies, Kamlesh Khunti, Karen Brown	32
6	Response to Comment on Zaccardi et al. Duration of Type 2 Diabetes and Incidence of Cancer: An Observational Study in England. Diabetes Care 2023;46:1923–1930 2023 ·Diabetes Care ·Francesco Zaccardi, Suping Ling, Karen Brown, Melanie J. Davies, Kamlesh Khunti	1
7	A Systematic Review Assessing Clinical Utility of Curcumin with a Focus on Cancer Prevention 2021 ·Molecular Nutrition & Food Research ·Lynne Howells, (unknown), (unknown), Coral Pepper, Anne Thomas, Karen Brown, Sameena Khan	20
8	Curcumin Combined with FOLFOX Chemotherapy Is Safe and Tolerable in Patients with Metastatic Colorectal Cancer in a Randomized Phase IIa Trial 2019 ·Journal of Nutrition ·Lynne Howells, Chinenye Iwuji, (unknown), Shaun Barber, Harriet S. Walter, (unknown), (unknown), Raj Singh, (unknown), Samita R. Patel, Bruno Morgan, William P. Steward, Andreas J. Gescher, Anne Thomas, Karen Brown	181
9	Circulating tumor DNA in patients with colorectal adenomas: assessment of detectability and genetic heterogeneity 2018 ·Cell Death and Disease ·(unknown), Ajay Verma, Daniel Fernández-García, Panchali Sarmah, Patrick Tarpey, (unknown), Hong Cai, Ricky M. Trigg, Kevin West, Lynne Howells, Anne Thomas, Karen Brown, David S. Guttery, Baljit Singh, (unknown), Ultan McDermott, Jacqui Shaw, Alessandro Rufini	38
10	An HPLC‐UV method for the simultaneous quantification of curcumin and its metabolites in plasma and lung tissue: Potential for preclinical applications 2018 ·Biomedical Chromatography ·(unknown), Lynne Howells, Rajinder Singh, Robert G. Britton, Hong Cai, Karen Brown	13
11	Effective mosquito and arbovirus surveillance using metabarcoding 2017 ·Molecular Ecology Resources ·Jana Batovska, (unknown), Noel O. I. Cogan, Karen Brown, (unknown), (unknown), Mark J. Blacket	49
12	Environmental and Veterinary History - Some Themes and Suggested Ways Forward 2014 ·Environment and History ·Karen Brown	5
13	Receipt of Genetic Counseling Recommendations Among Black Women at High Risk for BRCA Mutations 2012 ·Genetic Testing and Molecular Biomarkers ·Hayley S. Thompson, Katarina M. Sussner, Marc D. Schwartz, (unknown), Andrea Forman, Lina Jandorf, Karen Brown, Dana H. Bovbjerg, Heiðdís Valdimarsdóttir	20
14	Pilot Study of Oral Anthocyanins for Colorectal Cancer Chemoprevention 2009 ·Cancer Prevention Research ·Sarah Thomasset, David P. Berry, Hong Cai, Kevin West, Tim Marczylo, (unknown), Karen Brown, Ashley R. Dennison, Giuseppe Garcea, Andrew M. Miller, David Hemingway, William P. Steward, Andreas J. Gescher	90
15	Development of Dietary Phytochemical Chemopreventive Agents: Biomarkers and Choice of Dose for Early Clinical Trials 2009 ·Cancer Prevention Research ·Edwina N. Scott, Andreas J. Gescher, William P. Steward, Karen Brown	58
16	Mutagenicity of DNA adducts derived from ethylene oxide exposure in the pSP189 shuttle vector replicated in human Ad293 cells 2009 ·Mutation Research/Genetic Toxicology and Environmental Mutagenesis ·(unknown), Keith McLuckie, Donald J. L. Jones, Peter B. Farmer, Karen Brown	17
17	Telephone Genetic Counseling for High-Risk Women Undergoing BRCA1 and BRCA2 Testing: Rationale and Development of a Randomized Controlled Trial 2008 ·Genetic Testing ·Beth N. Peshkin, Tiffani A. DeMarco, Kristi D. Graves, Karen Brown, Rachel Nusbaum, (unknown), Andrea Forman, Heiðdís Valdimarsdóttir, Marc D. Schwartz	1
18	Telephone Genetic Counseling for High-Risk Women Undergoing BRCA1 and BRCA2 Testing: Rationale and Development of a Randomized Controlled Trial 2008 ·Genetic Testing ·Beth N. Peshkin, Tiffani A. DeMarco, Kristi D. Graves, Karen Brown, Rachel Nusbaum, (unknown), Andrea Forman, Heiðdís Valdimarsdóttir, Marc D. Schwartz	41
19	C-Terminal Signal Sequence Promotes Virulence Factor Secretion in Mycobacterium tuberculosis 2006 ·Science ·Patricia A. Champion, Sarah A. Stanley, Matthew M. Champion, Karen Brown, Jeffery S. Cox	167
20	Activation-enhanced α_IIbβ₃-Integrin–Cytoskeleton Interactions Outside of Focal Contacts Require the α-Subunit 2001 ·Molecular Biology of the Cell ·Dennis F. Kucik, Timothy E. O’Toole, Alexander Zheleznyak, (unknown), Karen Brown	15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact